Skip to content ↓

Topic

National Institutes of Health (NIH)

Download RSS feed: News Articles / In the Media / Audio

Displaying 1 - 15 of 311 news clips related to this topic.
Show:

Financial Times

The Financial Times’ Anjana Ahuja highlights Prof. Sangeeta Bhatia and Senior Postdoctoral Associate Vardhman Kumar’s work developing injectable “mini livers,” tissue grafts that could “take on some of the life-saving functions of liver cells: helping with blood clotting, detoxifying the bloodstream and breaking down medicines. The injectable grafts, they suggest, could also be used as a bridging treatment while patients wait for a transplant, with booster injections able to dial up the dose,” writes Ahuja.  

Earth.com

MIT researchers have discovered that peptides can remain stable and form into, reports Earth.com’s Eric Ralls. “First, we were astounded that peptides remain stable at all in concentrated sulfuric acid, for many weeks on end,” says Prof. Mei Hong, an author on the study. “Even more remarkable was that they adopt specific three-dimensional structures instead of random shapes.” 

Chemical & Engineering News

MIT researchers have discovered that peptides “not only survive in highly concentrated sulfuric acid but take on stable 3D conformations too,” writes Chemical & Engineering News’ Fionna Samuels. “The project started with a new collaboration between [Prof. Sara] Seager and the MIT chemist [Prof.] Mei Hong,” notes Samuels. “In the years since finding phosphine signals in Venusian clouds, Seager had been working her way through the building blocks of life—nucleic acids, amino acids, and lipids—to see if any survived concentrated acid exposure.”  

Health Day

MIT researchers found that unless an individual is affected by stroke or dementia, their ability to process language does not decline with age, writes Health Day’s Dennis Thompson. “Scans show that activity in the brain’s language processing network is nearly identical among seniors to that found in younger adults,” writes Thompson. “These results indicate that parts of the brain dedicated to unique functions like language might be less prone to age-related decline than general-purpose networks that contribute to many different skills.”  

VICE

MIT researchers have developed a new, breathable hydrogel material that is “packed with microscopic air tunnels inspired by the way human lungs move oxygen” and allows heat and sweat to escape, reports Luis Prada for VICE. “The material proved to be about 10 times more breathable than conventional hydrogels and retained about 95 percent of its airflow even after being stretched 10,000 times,” explains Prada. 

Newsweek

A new study by MIT researchers finds high-fat, low-carbohydrate ketogenic diets may increase the risk of certain intestinal cancers, writes Newsweek’s Daniella Gray. “The researchers say future studies will be needed to better understand how specific dietary fats influence cancer risk and whether modifying the composition of ketogenic diets could reduce potential harms while preserving any health benefits,” writes Gray.  

New York Post

MIT researchers found that the keto diet, which emphasizes low carbs and sugar, could increase the risk of tumors in the small intestine, explains New York Post reporter Allie Yang. The researchers found that “cells burning fat (from ketosis) start a chain reaction which leads to stem cells multiplying rapidly, increasing the chance they go out of control and become cancer,” Yang explains.  

Forbes

In a Forbes article, contributor Wes Kilgore cites a study by MIT economists that reveals how timely hospice use can create healthcare savings in the U.S. “When families avoid hospice because of fear or legal confusion, patients return to emergency rooms, see specialists, undergo procedures, and drive-up Medicare costs,” writes Kilgore. 

Medscape

Prof. Daniel Anderson speaks with Mandy Letterii at Medscape about his development of an implantable device for people with diabetes that can dispense islet cells directly into the body to manage blood sugar, which would eliminate the need for insulin injections. “We want to allow people to forget that they have diabetes,” says Anderson. “We’re not there yet, but that’s certainly what we hope to achieve.”

Inc.

A study by researchers at MIT and elsewhere has taken a deeper look at the “brief, frustrating moments after a bad night’s sleep when you simply can’t focus,” reports Bill Murphy for Inc. “The study suggested that the brain is juggling competing priorities,” explains Murphy. “During sleep, it performs what amounts to internal housekeeping, including fluid movement linked to clearing metabolic waste. During waking hours, it prioritizes attention and responsiveness. When sleep is cut short, those maintenance processes don’t disappear. Instead, they begin to intrude into waking life in short bursts, and attention drops at the same time.” 

Newsweek

Researchers at MIT have developed “mini livers” that “can be injected into the body to help take over the functions of a failing liver,” reports Ian Randall for Newsweek. “If realized clinically, the development could provide a lifeline for many of the more than 10,000 Americans with chronic liver disease currently waiting for a transplant,” writes Randall. 

Boston.com

Prof. Robert Langer, Prof. Giovanni Traverso and former postdoctoral fellow Thomas von Erlach founded Vivtex, a biotechnology startup that has “created a high-tech system called a ‘GI tract on a chip’ that uses robotics and AI to test how drugs move through the human digestive system,” reports Beth Treffeisen for Boston.com. “The technology allows Vivtex to quickly test thousands of drug formulations and predict how they will be absorbed in people, much more accurately than traditional lab methods.” 

The Boston Globe

Profs. Robert Langer, Giovanni Traverso and former postdoctoral fellow Thomas von Erlach have founded Vivtex, a biotechnology startup specializing in “oral alternatives to drugs administered by injections,” reports Jonathan Satlzman for The Boston Globe. Vivtex, now working in collaboration with Novo Nordisk, is looking to develop a new class of “pills to treat obesity and diabetes,” explains Saltzman. 

Interesting Engineering

MIT researchers have developed a deep-learning model “capable of predicting the precise movements, divisions, and restructuring of thousands of cells during the embryo’s transition from a simple cluster to a complex organism,” reports Mrigakshi Dixit for Interesting Engineering. “This model currently provides a sneak peek into the fruit fly’s earliest developmental stage,” explains Dixit. “In the future, it could be used to predict how more complex tissues, organs, and organisms develop.” 

Fox News

Reporting for FOX News, Kurt Knuttson highlights how MIT researchers have developed a new light-based scanner that can read blood sugar without a single prick. “A handheld or watch-sized glucose scanner would mark a major shift in diabetes care,” writes Knuttson. “MIT's work brings that future closer with a design that reads your chemistry through light.”